Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 (Broncho-Vaxom) for prevention of respiratory infection-triggered asthma exacerbations in children
ACTRN12614000062628Phase 3Terminated
- Sponsor
- The University of Queensland
- Start
- Apr 2014
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Mean number of lower respiratory events per patient over the treatment period. Started Apr 2014; status: terminated.
02
Drugs
OM-85
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12614000062628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000062628.